Great company, with huge prospects. The current CEO is a intellectual and is reseach focused. There is a lessened focus on the business.
My fingers count losses this financial year (06/07) - ballpark $1-1.5mill, mainly from the Soy venture/plant. Things may turn around if DHA sales exceed forecasts. Opportunities in the US are encouraging, however CLV is working behind its competitor, Martek. Martek are already producing DHA from microalgae.
watching
Add CLV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.5¢ |
Change
-0.005(1.02%) |
Mkt cap ! $60.11M | |||
| Open | High | Low | Value | Volume |
| 49.5¢ | 49.5¢ | 48.5¢ | $3.293K | 6.778K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 50480 | 48.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 44855 | 3 |
View Market Depth
| Last trade - 11.48am 18/11/2024 (20 minute delay) ? |
| CLV (ASX) Chart |
